INmune Bio, Inc. (INMB) vs Tenax Therapeutics, Inc. (TENX)
A side-by-side comparison of INmune Bio, Inc. and Tenax Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INMB
INmune Bio, Inc.
$1.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TENX
Tenax Therapeutics, Inc.
$1.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INMB vs TENX
growth of $100 · dividends reinvested · last 8yINMB -75.7% (-16.2%/yr)TENX -99.9% (-57.6%/yr)INMB compounded faster over this window
Log scale — wide-divergence pair
INMB TENX
INMB vs TENX: by the numbers
- •TENX is the larger company ($51M vs $50M market cap).
- •Both run net losses; TENX's is the smaller (0.00% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | INMB | TENX |
|---|---|---|
| P/B ratio | 2.44 | 0.45 |
Profitability
| Metric | INMB | TENX |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -61738.00% | 0.00% |
| Net margin | -91866.00% | 0.00% |
| ROE | -90.44% | -57.10% |
| ROIC | -96.37% | -60.40% |
Growth (annualized)
| Metric | INMB | TENX |
|---|---|---|
| Total return CAGR (5Y) | -36.88% | -76.80% |
Frequently asked
- How have INMB and TENX total returns compared?
- Over the past 5 years, INMB delivered -36.88% and TENX delivered -76.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.